Image Source: Zacks Investment Research Sanofi announced its intention to separate its CHC unit last year through ...

Sanofi gets rated buy today ... as it has been driving revenue from multiple products rather than a single magic drug.

Aspercreme, a topical pain relief cream brand, increased sales, purchase intent, and reach by capitalising on the TikTok trend of #HeelHacks. Aspercreme has been a trusted brand in the topical pain ...

The leading brands of Sanofi’s CHC business are the allergy products Allegra (2015 sales of €424m) and Nasacort (2015 sales of €122m) The deal is important for both companies, although ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

Little thought was given to media, and if it was, the advice from the environmentalist camp was to just cut back on advertising: no media, no carbon. Simple. Prasad Shridhar Ghag, global head of media ...